{{Rsnum
|rsid=6510827
|Gene=TICAM1
|Chromosome=19
|position=4830616
|Orientation=plus
|GMAF=0.3407
|Gene_s=TICAM1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 46.9 | 16.8
| HCB | 43.1 | 41.6 | 15.3
| JPT | 44.6 | 46.4 | 8.9
| YRI | 65.1 | 30.8 | 4.1
| ASW | 63.2 | 31.6 | 5.3
| CHB | 43.1 | 41.6 | 15.3
| CHD | 34.9 | 48.6 | 16.5
| GIH | 58.4 | 33.7 | 7.9
| LWK | 60.9 | 34.5 | 4.5
| MEX | 38.6 | 43.9 | 17.5
| MKK | 56.4 | 40.4 | 3.2
| TSI | 47.1 | 41.2 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22561518
|Trait=None
|Title=Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
|RiskAllele=T
|Pval=9E-8
|OR=1.1900
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}